Invacare Corporation Provides Update On Third Certification Report Relating To FDA Consent Decree

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) today announced that, while it has made significant progress on the final third-party expert certification audit relating to the quality systems at its corporate and Taylor Street manufacturing facilities in Elyria, Ohio, it has recently received additional input from the third-party expert. This input has clarified that some additional work is required in a few particular areas before the final certification report can be provided to the United States Food and Drug Administration (FDA). The final third-party certification audit is a comprehensive review of the Company’s compliance with the FDA’s Quality System Regulation (QSR) at the impacted Elyria facilities. The Company has already completed two third-party expert certification audits, and the FDA has found the results of both to be acceptable. In the first two audits, the third-party expert certified that the Company’s equipment and process validation procedures and its design control systems were compliant with the FDA’s QSR.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC